{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:04:33Z","timestamp":1778216673035,"version":"3.51.4"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neuroscience.2025.08.051","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:52:43Z","timestamp":1756828363000},"page":"233-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects"],"prefix":"10.1016","volume":"585","author":[{"given":"Sakshi","family":"Rai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amritha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirha","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman Kumar","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat R.","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhes","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/biom12040591","article-title":"Aquaporin-4 in neuromyelitis optica spectrum disorders: a target of autoimmunity in the central nervous system","volume":"12","author":"Abe","year":"2022","journal-title":"Biomolecules"},{"issue":"18","key":"10.1016\/j.neuroscience.2025.08.051_b0010","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.3390\/ijms231810572","article-title":"Glial cell-mediated neuroinflammation in Alzheimer's disease","volume":"23","author":"Al-Ghraiybah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.08.051_b0015","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.3390\/ijms242216288","article-title":"Blood-brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0025","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.2147\/IJN.S333657","article-title":"Potential of nanocarrier-based drug delivery systems for brain targeting: a current review of literature","volume":"16","author":"Alotaibi","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2025.08.051_b0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0045","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials (Basel, Switzerland)"},{"issue":"40","key":"10.1016\/j.neuroscience.2025.08.051_b0050","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/glia.22654","article-title":"What is microglia neurotoxicity (not)?","volume":"62","author":"Biber","year":"2016","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.08.051_b0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1289\/ehp.1204934","article-title":"Predicting later-life outcomes of early-life exposures","volume":"120","author":"Boekelheide","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"24","key":"10.1016\/j.neuroscience.2025.08.051_b0070","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/pharmaceutics15010298","article-title":"Exosomes-based nanomedicine for neurodegenerative diseases: current insights and future challenges","volume":"15","author":"Cano","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and therapeutic relevance of neuro-immune communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-parkinsonian therapy: strategies for crossing the blood-brain barrier and nano-biological effects of nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano-Micro Letters"},{"issue":"6276","key":"10.1016\/j.neuroscience.2025.08.051_b0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Sci. (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.08.051_b0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson's Disease: a multisystem disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-051222-120750","article-title":"Neurodegenerative disease tauopathies","volume":"19","author":"Creekmore","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155101","article-title":"Natural products for the treatment of neurodegenerative diseases","volume":"121","author":"Cui","year":"2023","journal-title":"Phytomed.: Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer's & Dementia (New York, N. Y.)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0120","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimer's & Dementia (New York, N. Y.)"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","article-title":"Quercetin: a flavonol with multifaceted therapeutic applications?","volume":"106","author":"D'Andrea","year":"2015","journal-title":"Fitoterapia"},{"issue":"17","key":"10.1016\/j.neuroscience.2025.08.051_b0135","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.3390\/molecules29174056","article-title":"Latest perspectives on Alzheimer's disease treatment: the role of blood-brain barrier and antioxidant-based drug delivery systems","volume":"29","author":"Daraban","year":"2024","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"Pt A","key":"10.1016\/j.neuroscience.2025.08.051_b0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijbiomac.2020.09.232","article-title":"Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation","volume":"165","author":"Das","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-212922","article-title":"Preventing Parkinson's disease: an environmental agenda","volume":"12","author":"De Miranda","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0160","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","article-title":"Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer's disease therapy","volume":"9","author":"Dos Santos","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2011-3-2-34-55","article-title":"Gold nanoparticles in biology and medicine: recent advances and prospects","volume":"3","author":"Dykman","year":"2011","journal-title":"Acta Nat."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as biocompatible and smart delivery systems - the current state","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fphar.2020.00886","article-title":"Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD?","volume":"11","author":"Eissa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153324","article-title":"Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model","volume":"79","author":"Elibol","year":"2020","journal-title":"Phytomed. : Int. J. Phytother. Phytopharmacol."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"The Lancet. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0205","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson's disease treatment: past, present, and future","volume":"127","author":"Elsworth","year":"2020","journal-title":"J. Neural Trans. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6241017","article-title":"Rutin as a potent antioxidant: implications for neurodegenerative disorders","volume":"2018","author":"Enogieru","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108830","article-title":"Neuroimmune modulators derived from natural products: mechanisms and potential therapies","volume":"269","author":"Feng","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.718188","article-title":"Green tea polyphenol epigallocatechin-gallate in amyloid aggregation and neurodegenerative diseases","volume":"15","author":"Fernandes","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0230","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.2147\/IJN.S87148","article-title":"Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease","volume":"10","author":"Fonseca-Santos","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"issue":"1652","key":"10.1016\/j.neuroscience.2025.08.051_b0240","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0510","article-title":"Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation","volume":"369","author":"Fr\u00f6hlich","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0245","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-021-08899-6","article-title":"Immunology of aging: the birth of inflammaging","volume":"64","author":"Fulop","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"46","key":"10.1016\/j.neuroscience.2025.08.051_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater. (Deerfield Beach Fla.)"},{"issue":"18","key":"10.1016\/j.neuroscience.2025.08.051_b0260","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0265","doi-asserted-by":"crossref","unstructured":"GBD 2016 Neurology Collaborators. (2019). Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis. The Lancet Neurology, 18(5), 459\u2013480. doi: 10.1016\/S1474-4422(18)30499-X.","DOI":"10.1016\/S1474-4422(19)30029-8"},{"issue":"26","key":"10.1016\/j.neuroscience.2025.08.051_b0270","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.08.051_b0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2174\/1871527315666160815164247","article-title":"Neural stem cell transplantation and CNS diseases","volume":"15","author":"Gonzalez","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","article-title":"Mechanisms underlying T cell ageing","volume":"19","author":"Goronzy","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.782657","article-title":"Neuroprotection by the Ketogenic diet: evidence and controversies","volume":"8","author":"Gough","year":"2021","journal-title":"Front. Nutr."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0290","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0295","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0300","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ncl.2023.07.006","article-title":"Bruton's tyrosine kinase inhibitors for multiple sclerosis treatment: a new frontier","volume":"42","author":"Greenberg","year":"2024","journal-title":"Neurol. Clin."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.08.051_b0310","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40364-022-00374-4","article-title":"Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications","volume":"10","author":"Hazrati","year":"2022","journal-title":"Biomarker Res."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0325","article-title":"Neuroinflammation in Alzheimer disease","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.immuni.2017.06.007","article-title":"Myeloid cells in the central nervous system","volume":"46","author":"Herz","year":"2017","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0335","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0340","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ana.26861","article-title":"Long-term downregulation of the sodium channel gene scn8a is therapeutic in mouse models of SCN8A epilepsy","volume":"95","author":"Hill","year":"2024","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.08.051_b0345","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5493\/wjem.v4.i3.27","article-title":"Multiple sclerosis and the role of immune cells","volume":"4","author":"H\u00f8glund","year":"2014","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis failure in neurodegenerative diseases: focus on oxidative stress","volume":"2020","author":"H\u00f6hn","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109952","article-title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: a revolution in the making?","volume":"253","author":"H\u00f6lscher","year":"2024","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0365","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0370","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0375","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1007\/s00018-021-03785-y","article-title":"Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders","volume":"78","author":"Irollo","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.08.051_b0380","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.1039\/D3RA01635H","article-title":"A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety","volume":"13","author":"Ismail","year":"2023","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.neuroscience.2025.08.051_b0385","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.3390\/ijms22169082","article-title":"Nanomedicine for neurodegenerative disorders: focus on Alzheimer's and Parkinson's diseases","volume":"22","author":"Jagaran","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.neuroscience.2025.08.051_b0390","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.3390\/ijms241613021","article-title":"From pathogenesis to therapeutics: a review of 150 years of Huntington's disease research","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.neuroscience.2025.08.051_b0395","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer's disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0400","doi-asserted-by":"crossref","unstructured":"Kappos, L., Radue, E. W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., Burtin, P., & FREEDOMS Study Group (2010). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New England J. Med., 362(5), 387\u2013401. doi: 10.1056\/NEJMoa0909494.","DOI":"10.1056\/NEJMoa0909494"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.08.051_b0405","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.trecan.2023.05.002","article-title":"Neuro-immune interactions and immuno-oncology","volume":"9","author":"Khanmammadova","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114945","article-title":"Metformin in Alzheimer's disease: an overview of potential mechanisms, preclinical and clinical findings","volume":"197","author":"Khezri","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.neuroscience.2025.08.051_b0415","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.0402268101","article-title":"T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions","volume":"101","author":"Kipnis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0420","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.2147\/IJN.S497859","article-title":"Physicochemical property effects on immune modulating polymeric nanoparticles: potential applications in spinal cord injury","volume":"19","author":"Kolpek","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.08.051_b0430","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4103\/1673-5374.194804","article-title":"Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response","volume":"11","author":"Koudriavtseva","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0435","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Trans. Neurodegen."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: current trends and future perspectives","volume":"16","author":"La Barbera","year":"2022","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0445","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"Pt A, 2\u20137","key":"10.1016\/j.neuroscience.2025.08.051_b0450","article-title":"Multiple sclerosis: lessons from molecular neuropathology","volume":"262","author":"Lassmann","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1144036","article-title":"Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease","volume":"15","author":"Lee","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","article-title":"Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair","volume":"36","author":"Lemus","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0465","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracellular Vesicles"},{"issue":"9451","key":"10.1016\/j.neuroscience.2025.08.051_b0470","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0475","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0480","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of Neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.08.051_b0485","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","article-title":"CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature","volume":"21","author":"Louveau","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0490","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.008","article-title":"Caloric restriction reprograms the single-cell transcriptional landscape of rattus norvegicus aging","volume":"180","author":"Ma","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0505","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/biom12071001","article-title":"Comparison of Tau and Amyloid-\u03b2 targeted immunotherapy nanoparticles for Alzheimer's disease","volume":"12","author":"Mashal","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0510","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/238428","article-title":"Nanoparticles for brain drug delivery","volume":"2013","author":"Masserini","year":"2013","journal-title":"ISRN Biochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0515","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.08.051_b0520","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/jpm11111116","article-title":"Mechanisms involved in microglial-interceded Alzheimer\u2019s disease and nanocarrier-based treatment approaches","volume":"11","author":"Md","year":"2021","journal-title":"J. Personalized Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0525","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0530","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine a to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0535","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0540","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/tnsci-2022-0258","article-title":"Nanotechnology-based drug delivery for the treatment of CNS disorders","volume":"13","author":"Mittal","year":"2022","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0545","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8844030","article-title":"Dendrimers: a new race of pharmaceutical nanocarriers","volume":"2021","author":"Mittal","year":"2021","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0550","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0555","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/ijms24010340","article-title":"Therapeutic effects of green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis","volume":"24","author":"Mokra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 8","key":"10.1016\/j.neuroscience.2025.08.051_b0560","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","article-title":"Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy","volume":"120","author":"Moser","year":"1997","journal-title":"Brain J. Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.08.051_b0565","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0570","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2967\/jnumed.113.131045","article-title":"Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study","volume":"55","author":"Nakatomi","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0595","doi-asserted-by":"crossref","unstructured":"Oosterloo, M., Touze, A., Byrne, L. M., Achenbach, J., Aksoy, H., Coleman, A., Lammert, D., Nance, M., Nopoulos, P., Reilmann, R., Saft, C., Santini, H., Squitieri, F., Tabrizi, S., Burgunder, J. M., Quarrell, O., & Pediatric Huntington Disease Working Group of the European Huntington Disease Network (2024). Clinical Review of Juvenile Huntington's Disease. J. Huntington's Dis., 13(2), 149\u2013161. doi: 10.3233\/JHD-231523.","DOI":"10.3233\/JHD-231523"},{"issue":"21","key":"10.1016\/j.neuroscience.2025.08.051_b0600","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.3390\/ijms242115635","article-title":"Exosomes interactions with the blood-brain barrier: implications for cerebral disorders and therapeutics","volume":"24","author":"Osaid","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.796378","article-title":"The neuroimmunology of multiple sclerosis: fictions and facts","volume":"12","author":"Pachner","year":"2022","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0610","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"The Lancet. Neurol."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.08.051_b0615","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0620","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/pharmaceutics15030837","article-title":"Nanocarriers for the delivery of neuroprotective agents in the treatment of ocular neurodegenerative diseases","volume":"15","author":"Patel","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0625","first-page":"1","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"114","author":"Patel","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0630","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0635","first-page":"161","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"10","author":"Perry","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0640","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"6933","key":"10.1016\/j.neuroscience.2025.08.051_b0645","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","article-title":"Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis","volume":"422","author":"Pluchino","year":"2003","journal-title":"Nature"},{"issue":"9 Suppl 2","key":"10.1016\/j.neuroscience.2025.08.051_b0650","first-page":"S38","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus-myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0660","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0665","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190062","article-title":"The blood-brain barrier in health and disease: important unanswered questions","volume":"217","author":"Profaci","year":"2020","journal-title":"J. Exp. Med."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.08.051_b0670","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.3390\/ijms241814044","article-title":"Advancements in the application of nanomedicine in Alzheimer's disease: a therapeutic perspective","volume":"24","author":"Puranik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1011740","article-title":"Natural product-based pharmacological studies for neurological disorders","volume":"13","author":"Puri","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"46","key":"10.1016\/j.neuroscience.2025.08.051_b0680","doi-asserted-by":"crossref","first-page":"15482","DOI":"10.1523\/JNEUROSCI.3258-14.2014","article-title":"Emerging roles of extracellular vesicles in the nervous system","volume":"34","author":"Rajendran","year":"2014","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.08.051_b0685","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3390\/cells11121885","article-title":"Innate immune cell death in neuroinflammation and Alzheimer's disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0690","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0695","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0700","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","article-title":"Age and age-related diseases: role of inflammation triggers and cytokines","volume":"9","author":"Rea","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0705","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/cells9071717","article-title":"Microglia: agents of the CNS Pro-Inflammatory Response","volume":"9","author":"Rodr\u00edguez-G\u00f3mez","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.08.051_b0710","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/biom11081131","article-title":"Transportation of single-domain antibodies through the blood-brain barrier","volume":"11","author":"Ruiz-L\u00f3pez","year":"2021","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0715","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0720","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","article-title":"Primary central nervous system vasculitis: analysis of 101 patients","volume":"62","author":"Salvarani","year":"2007","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.08.051_b0725","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.08.051_b0745","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","article-title":"Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation","volume":"37","author":"Schwartz","year":"2016","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0750","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/jpm12091515","article-title":"Multi-target mechanisms of phytochemicals in alzheimer's disease: effects on oxidative stress, neuroinflammation and protein aggregation","volume":"12","author":"Sharifi-Rad","year":"2022","journal-title":"J. Personalized Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0755","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-021-02114-1","article-title":"A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury","volume":"18","author":"Sharma","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0760","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0765","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0775","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.12170","article-title":"Mast cells, glia and neuroinflammation: partners in crime?","volume":"141","author":"Skaper","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer's disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Trans. Neurodegen."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.08.051_b0785","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.0000000000003987","article-title":"Autologous hematopoietic stem cell transplantation in multiple sclerosis: a meta-analysis","volume":"88","author":"Sormani","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0790","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0795","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.602269","article-title":"Bone angiogenesis and vascular niche remodeling in stress, aging, and diseases","volume":"8","author":"Stucker","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0800","first-page":"235","article-title":"Long-term safety of multiple sclerosis therapies","volume":"20","author":"Stuve","year":"2021","journal-title":"The Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.08.051_b0805","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0810","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"The Lancet. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.08.051_b0820","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0825","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","article-title":"Role of neutrophils in spinal cord injury in the rat","volume":"79","author":"Taoka","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnsys.2018.00039","article-title":"Neuroimmune activation drives multiple brain states","volume":"12","author":"Tchessalova","year":"2018","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0835","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.actbio.2024.09.027","article-title":"Navigating neurotoxicity and safety assessment of nanocarriers for brain delivery: strategies and insights","volume":"189","author":"Teixeira","year":"2024","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.08.051_b0840","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0845","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0850","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"The Lancet. Neurology"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0855","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.3390\/ijms25073845","article-title":"Huntington's disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0860","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer's disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.08.051_b0870","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1038\/tp.2015.100","article-title":"Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?","volume":"5","author":"van Buel","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0875","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1460-9568.2004.03593.x","article-title":"Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions","volume":"20","author":"Verge","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.08.051_b0880","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/13543784.2020.1757647","article-title":"New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis","volume":"29","author":"Villoslada","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0890","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1142\/S0192415X13500055","article-title":"Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein","volume":"41","author":"Wang","year":"2013","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.08.051_b0900","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0905","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/IJN.S395010","article-title":"Nanotherapeutic and stem cell therapeutic strategies in neurodegenerative diseases: a promising therapeutic approach","volume":"18","author":"Wei","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0915","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.2147\/IJN.S484838","article-title":"Nanoparticle-based drug delivery systems enhance treatment of cognitive defects","volume":"19","author":"Wilar","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"10045","key":"10.1016\/j.neuroscience.2025.08.051_b0920","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0930","doi-asserted-by":"crossref","unstructured":"Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J. H., Tenembaum, S., Traboulsee, A. L., Waters, P., Wellik, K. E., Weinshenker, B. G., & International Panel for NMO Diagnosis (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 85(2), 177\u2013189. doi: 10.1212\/WNL.0000000000001729.","DOI":"10.1212\/WNL.0000000000001729"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0935","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/pharmaceutics14040836","article-title":"Lipid-based nanocarriers for neurological disorders: a review of the state-of-the-art and therapeutic success to date","volume":"14","author":"Witika","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2025.08.051_b0940","article-title":"CNS and CNS diseases in relation to their immune system","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.08.051_b0945","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2025.08.051_b0950","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.08.051_b0955","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.08.051_b0960","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/10408398.2022.2113361","article-title":"Virgin coconut oil: a comprehensive review of antioxidant activity and mechanisms contributed by phenolic compounds","volume":"64","author":"Zeng","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.08.051_b0965","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer's disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0970","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.08.051_b0975","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225009005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225009005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:43:15Z","timestamp":1758832995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225009005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":180,"alternative-id":["S0306452225009005"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.08.051","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}